Resources


The Lewin Group Center for Comparative Effectiveness Research combines consulting, research, and data assets to advance the health care industry's understanding—and application—of the most effective clinical protocols available.

We invite you to review the downloadable resources in our archives to examine our work in greater detail:

CER UPDATES
LEARN MORE ABOUT OUR CER RELATED WORK

 Full reference and link to abstract PubMed Reference
Harley CR, Gandhi S, Heien H, Nelson SP. The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal. Int J Clin Pract. 2008;62(6):889-95. PM:18479282
Harley CR, Gandhi SK, Heien H, McDonough K, Nelson SP. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opin Pharmacother. 2008;9(5):669-76. PM:18345946
Stanford RH, Fuhlbrigge A, Riedel A, Rey GG, Stempel D. An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes. Curr.Med.Res.Opin. 2008:24(11):3141-8. PM:18838055
Xin Y, Sikirica V, Schein J, Grant R, Zarotsky V, Doshi D, Benson C, Riedel A. Treatment Failure Rates and Health Care Utilization and Costs Among Patients with Community-Acquired Pneumonia Treated with Levofloxacin or Macrolides in an Outpatient Setting: A Retrospective Claims Database Analysis. Clin Ther, 2008;30(2): 358-371. PM:18343274
Kobelt G, Berg J. Lindgren P, Jonsson B, Stawiarz L, Hillert J. Modeling the Cost-Effectiveness of a New Treatment for MS (natalizumab) compared to Current Standard Practice in Sweden. Multiple Sclerosis 2008;14(5):679-90. PM:18566030
Lindgren P, Buxton M, Kahan T, Poulter N, Dahlöf B, Sever S, Wedel H, Jönsson B. Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlopidine based treatment is cost-effective compared to an atenolol-based regimen. ASCOT Trial Investigators. Heart 2008;94(2):e4. PM:17916665
Aballea S, Cure S, Vogelmeier C, Wiren A. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta (2)-agonists for asthma maintenance treatment in Germany. Int J Clin Pract. 2008;62(12):1870-9. PM:18803555
Quilici S, Abrams KR, Nicolas A, Martin M, Petit C, Lieu PL, Finnern HW. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless leg syndrome. Sleep Med. 2008;9(7):715-26. PM:18226947
Quilici S, Chancellor J, Lothgren M, Simon D, Said G, Kim Le T, Garcia-Cebrian A, Monz B. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. BMC Neurology 2009;9:6.
PM:19208243